Cheelcare Secures Canadian Patent for Companion Power Assist Platform
Reported by TMX Newsfile
Sentiment
Positive
Importance
7
Price
$0.655
Mkt Cap
0
52W Low
$0.655
52W High
$0.655
Market data snapshot near publication time
Summary
Cheelcare Inc. has been granted a Canadian patent for its Companion power assist platform, protecting core interface technologies. This strengthens the company's intellectual property for a key product that has recently seen record monthly bookings in March and April 2026. The patent, which follows a previously granted U.S. patent, supports long-term product differentiation and commercialization as the company expands reimbursement-supported access and dealer networks.
At the time of this announcement, CHCRF was trading at $0.66 on OTC in the Life Sciences sector. The 52-week trading range was $0.66 to $0.66. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.